Recent News

• 03.30.2026 - BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease
• 03.19.2026 - BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease
• 03.19.2026 - BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease
• 03.05.2026 - BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026
• 03.05.2026 - BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026
• 03.04.2026 - BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy
• 03.04.2026 - BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy
• 02.24.2026 - BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
• 02.24.2026 - BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
• 02.14.2026 - BioRestorative Announces Closing of $5.0 Million Public Offering

Recent Filings

• 03.26.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.23.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.18.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - 8-K Current report
• 02.17.2026 - EX-99.1 EX-99.1
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.13.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.13.2026 - 424B4 Prospectus [Rule 424(b)(4)]